POM to P switch for Sudafed Plus Blocked Nose nasal spray
Sudafed Plus Blocked Nose 1mg/50mg/ml nasal spray will become available to buy in pharmacies without a prescription.
The Medicines and Healthcare products Regulatory Agency (MHRA) has decided that the nasal spray is “sufficiently safe to be sold as a pharmacy (P) medicine”, it announced today (August 3).
It follows an application by its marketing authorisation holder, McNeil Products Limited, to reclassify the prescription-only medicine (POM) to a P medicine.
The nasal spray contains xylometazoline hydrochloride 1mg/ml (0.1% w/v) and dexpathenol 50mg/ml (5% w/v).
The MHRA came to the decision having reviewed a raft of evidence about the drug and assessing any potential of risk to patient safety.
Pharmacists will now be able to dispense the nasal spray solution without prescription to adults and children aged 12 years and older suffering from nasal congestion.
C+D has asked the MHRA when the reclassification will come into effect.
